Telemus Capital, LLC Eli Lilly & CO Transaction History

Telemus Capital, LLC

$1.2 Billion
Q4 2023

A detailed history of Telemus Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Telemus Capital, LLC holds 2,322 shares of LLY stock, worth $2.05 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,322

Previous 2,254 3.02%

Holding current value

$2.05 Million

Previous $1.21 Million 11.82%

% of portfolio

0.11%

Previous 0.11%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$525.19 - $619.13 $35,712 - $42,100	68 Added 3.02%	2,322 $1.35 Million
Q3 2023 Oct 25, 2023	SELL	$434.7 - $599.3 $262,124 - $361,377	-603 Reduced 21.11%	2,254 $1.21 Million
Q2 2023 Jul 10, 2023	BUY	$350.74 - $468.98 $20,342 - $27,200	58 Added 2.07%	2,857 $1.34 Million
Q1 2023 Apr 11, 2023	BUY	$310.63 - $364.82 $6,833 - $8,026	22 Added 0.79%	2,799 $961,000
Q4 2022 Jan 11, 2023	BUY	$321.55 - $374.67 $9,968 - $11,614	31 Added 1.13%	2,777 $0
Q3 2022 Oct 11, 2022	SELL	$296.48 - $337.87 $21,050 - $23,988	-71 Reduced 2.52%	2,746 $888,000
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $199,570 - $234,325	716 Added 34.08%	2,817 $913,000
Q1 2022 Apr 06, 2022	BUY	$234.69 - $291.66 $37,785 - $46,957	161 Added 8.3%	2,101 $602,000
Q4 2021 Feb 01, 2022	BUY	$224.85 - $279.04 $2,698 - $3,348	12 Added 0.62%	1,940 $536,000
Q3 2021 Oct 27, 2021	BUY	$221.6 - $272.71 $39,888 - $49,087	180 Added 10.3%	1,928 $445,000
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $688,978 - $891,188	-3,816 Reduced 68.58%	1,748 $401,000
Q1 2021 Apr 20, 2021	SELL	$164.32 - $212.72 $189,460 - $245,266	-1,153 Reduced 17.17%	5,564 $1.03 Million
Q4 2020 Jan 28, 2021	SELL	$130.46 - $172.63 $635,992 - $841,571	-4,875 Reduced 42.05%	6,717 $1.13 Million
Q3 2020 Nov 02, 2020	BUY	$146.22 - $169.13 $14,622 - $16,913	100 Added 0.87%	11,592 $1.69 Million
Q2 2020 Jul 17, 2020	BUY	$136.42 - $164.18 $19,371 - $23,313	142 Added 1.25%	11,492 $1.88 Million
Q1 2020 Jun 05, 2020	BUY	$119.05 - $147.35 $297,505 - $368,227	2,499 Added 28.23%	11,350 $1.74 Million
Q4 2019 Jan 24, 2020	BUY	$106.92 - $132.43 $32,289 - $39,993	302 Added 3.53%	8,851 $1.16 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $30,541 - $33,221	286 Added 3.46%	8,549 $955,000
Q2 2019 Aug 09, 2019	SELL	$110.79 - $129.32 $22,490 - $26,251	-203 Reduced 2.4%	8,263 $898,000
Q1 2019 May 02, 2019	BUY	$111.31 - $131.02 $212,490 - $250,117	1,909 Added 29.11%	8,466 $1.1 Million
Q4 2018 Feb 06, 2019	BUY	$105.9 - $118.64 $694,386 - $777,922	6,557 New	6,557 $759,000
Q1 2018 Apr 27, 2018	SELL	$74.21 - $87.6 $14,841 - $17,520	-200 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$81.94 - $87.89 $16,388 - $17,578	200	200 $17,000

Others Institutions Holding LLY

# of Institutions

4,267

Shares Held

757M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $837B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Telemus Capital, LLC with notifications on news.

Account

Telemus Capital, LLC Eli Lilly & CO Transaction History